It’s unfair to call treatments untested. Medications are tested extensively. The FDA could work with sponsors to come up with a range of risk profiles and expand access.
They indeed do this and have various avenues for treatments to be approved on expedited timelines.
BTW people picking such experimental treatments would provide important data points.